Distinguished senior healthcare executive,
Theresa Firestone, to fill newly
added position
NASDAQ | TSX: ACB
EDMONTON, AB, July 26, 2021 /PRNewswire/ - Aurora Cannabis Inc.
(the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB),
the Canadian company defining the future of cannabinoids worldwide,
announced today the appointment of Theresa
Firestone to the Company's Board of Directors (the "Board"),
effective today. This is a newly created directorship that expands
the Board to nine members, seven of whom are independent.
Ms. Firestone joins the Board following a distinguished career
as a senior healthcare executive with leadership positions in
Canada, Europe and Asia. An expert in strategic planning,
operations and new business development, Ms. Firestone has served
in various sectors such as retail, healthcare, pharmaceuticals and
government. Her experience includes over 20 years of international
P&L management, 15 years in senior roles at Pfizer Inc., over
ten years at the Ontario Ministry of Health and seven years in
retail and health and wellness, including Shoppers Drug Mart where
she oversaw the design and launch of the company's Medical Cannabis
business. In addition, Ms. Firestone has more than 20 years of
public and private board experience including with Orion
Biotechnology, Merus Labs International and several not-for-profit
organizations.
Ronald Funk, Chairman of Aurora
Cannabis stated, "We are delighted to welcome Theresa to our Board
of Directors. She brings to us extensive expertise in
healthcare management and pharmaceuticals, global business
restructuring, new business development and a proven ability to
lead and manage change. Her background and well-defined skillset
will be invaluable to us as we execute our strategic growth plans
while managing costs more effectively. We look forward to
benefitting from her many contributions to Aurora."
Ms. Firestone holds a Bachelor of Applied Science from the
University of Guelph and completed the
Executive Leadership Program at Harvard
Business School. Accolades include induction into the
Canadian Healthcare Marketing Hall of Fame, honoured as one of 12
Outstanding Canadian Women by the Weizman Institute and awarded the
prestigious Queen's Golden Jubilee
medal.
About Aurora
Aurora is a global leader in the cannabis industry serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler,
and Reliva CBD. Driven by science and innovation, and with a focus
on high-quality cannabis products, Aurora's brands continue to
break through as industry leaders in the medical, performance,
wellness and recreational markets wherever they are launched. For
more information, please visit our website at www.auroramj.com.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB" and is a constituent of the S&P/TSX Composite
Index.
Forward-looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in
this news release include statements regarding the Company's
execution of strategic growth plans while managing costs. These
forward-looking statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward looking statements are based on the
opinions, estimates and assumptions of management in light of
management's experience and perception of historical trends,
current conditions and expected developments at the date the
statements are made, such as current and future market conditions,
the ability to maintain SG&A costs in line with current
expectations, the ability to achieve high margin revenues in the
Canadian consumer market, the current and future regulatory
environment and future approvals and permits. Forward-looking
statements are subject to a variety of risks, uncertainties and
other factors that management believes to be relevant and
reasonable in the circumstances could cause actual events, results,
level of activity, performance, prospects, opportunities or
achievements to differ materially from those projected in the
forward-looking statements, including the risks associated with:
entering the U.S. market, the ability to realize the anticipated
benefits associated with the acquisition of Reliva, achievement of
Aurora's business transformation plan, general business and
economic conditions, changes in laws and regulations, product
demand, changes in prices of required commodities, competition, the
effects of and responses to the COVID-19 pandemic and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 24, 2020 (the "AIF") and filed with
Canadian securities regulators available on the Company's issuer
profile on SEDAR at www.sedar.com and filed with and available on
the SEC's website at www.edgar.gov. The Company cautions that the
list of risks, uncertainties and other factors described in the AIF
is not exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the risks, uncertainties and
assumptions carefully in evaluating the forward-looking statements
and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities
law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-announces-appointment-of-new-independent-director-301340664.html
SOURCE Aurora Cannabis Inc.